↓ Skip to main content

Cognitive Enhancement

Overview of attention for book
Attention for Chapter 10: Social cognition.
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
92 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Social cognition.
Chapter number 10
Book title
Cognitive Enhancement
Published in
Handbook of experimental pharmacology, January 2015
DOI 10.1007/978-3-319-16522-6_10
Pubmed ID
Book ISBNs
978-3-31-916521-9, 978-3-31-916522-6
Authors

Patin, Alexandra, Hurlemann, René, Alexandra Patin, René Hurlemann

Abstract

Social cognition is a major problem underlying deficiencies in interpersonal relationships in several psychiatric populations. And yet there is currently no gold standard for pharmacological treatment of psychiatric illness that directly targets these social cognitive areas. This chapter serves to illustrate some of the most innovative attempts at pharmacological modulation of social cognition in psychiatric illnesses including schizophrenia, borderline personality disorder, autism spectrum disorders, antisocial personality disorder and psychopathy, social anxiety disorder, and posttraumatic stress disorder. Pharmacological modulation includes studies administering oxytocin, ecstasy (MDMA), modafinil, methylphenidate, and D-cycloserine. Furthermore, some background on social cognition research in healthy individuals, which could be helpful in developing future treatments, is provided as well as the potential for each drug as a long-term treatment option.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 92 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 1%
Unknown 91 99%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 16 17%
Student > Bachelor 12 13%
Student > Postgraduate 7 8%
Researcher 7 8%
Student > Master 6 7%
Other 14 15%
Unknown 30 33%
Readers by discipline Count As %
Psychology 26 28%
Medicine and Dentistry 10 11%
Neuroscience 8 9%
Agricultural and Biological Sciences 3 3%
Biochemistry, Genetics and Molecular Biology 2 2%
Other 10 11%
Unknown 33 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 May 2015.
All research outputs
#14,812,046
of 22,805,349 outputs
Outputs from Handbook of experimental pharmacology
#374
of 648 outputs
Outputs of similar age
#197,985
of 353,075 outputs
Outputs of similar age from Handbook of experimental pharmacology
#38
of 65 outputs
Altmetric has tracked 22,805,349 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 648 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.2. This one is in the 39th percentile – i.e., 39% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 353,075 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 65 others from the same source and published within six weeks on either side of this one. This one is in the 36th percentile – i.e., 36% of its contemporaries scored the same or lower than it.